Avenir Wellness Solutions, Inc.
AVRW
$0.03
-$0.003-9.09%
| Weiss Ratings | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.88 | |||
| Price History | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 20.00% | |||
| 30-Day Total Return | 7.14% | |||
| 60-Day Total Return | -33.33% | |||
| 90-Day Total Return | 81.82% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -19.14% | |||
| 2-Year Total Return | -80.33% | |||
| 3-Year Total Return | -87.49% | |||
| 5-Year Total Return | -98.56% | |||
| 52-Week High % Change | -42.61% | |||
| 52-Week Low % Change | 144.44% | |||
| Price | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.06 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Oct 30, 2024 | |||
| 52-Week High Price (Date) | Nov 21, 2024 | |||
| Valuation | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.60M | |||
| Enterprise Value | 11.45M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | -76.08% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.27 | |||
| Price/Book (Q) | -0.21 | |||
| Enterprise Value/Revenue (TTM) | 5.61 | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -3.84 | |||
| Enterprise Value/EBIT | -3.75 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 78.44M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 424 273 8675 | |||
| Address | 5805 Sepulveda Boulevard Sherman Oaks, CA 91411 | |||
| Website | www.avenirwellness.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -149.82% | |||
| Profit Margin | -135.08% | |||
| Management Effectiveness | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -107.10% | |||
| Return on Equity | -- | |||
| Income Statement | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.04M | |||
| Total Revenue (TTM) | 2.04M | |||
| Revenue Per Share | $0.03 | |||
| Gross Profit (TTM) | 1.43M | |||
| EBITDA (TTM) | -2.98M | |||
| EBIT (TTM) | -3.06M | |||
| Net Income (TTM) | -2.76M | |||
| Net Income Avl. to Common (TTM) | -2.76M | |||
| Total Revenue Growth (Q YOY) | -81.01% | |||
| Earnings Growth (Q YOY) | 75.67% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | 77.60% | |||
| Balance Sheet | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 238.00K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -12.55M | |||
| Current Ratio (Q) | 0.018 | |||
| Book Value Per Share (Q) | -$0.16 | |||
| Total Assets (Q) | 748.00K | |||
| Total Current Liabilities (Q) | 13.30M | |||
| Total Debt (Q) | 8.86M | |||
| Total Liabilities (Q) | 13.30M | |||
| Total Common Equity (Q) | -12.55M | |||
| Cash Flow | AVRW - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.25M | |||
| Cash from Financing (TTM) | 121.00K | |||
| Net Change in Cash (TTM) | -178.00K | |||
| Levered Free Cash Flow (TTM) | 54.50K | |||
| Cash from Operations (TTM) | -1.55M | |||
